Skip to content

MaRS Innovation collaborating with Johnson & Johnson Innovation and Janssen to advance Cardiac, Diabetes and Depression technologies

mi_logoTORONTO, Jan. 12, 2015  — MaRS Innovation, the commercialization agent for Ontario’s 15 leading academic institutions, today announced that it has formed a research collaboration with Johnson & Johnson Innovation, LLC and its Canadian affiliate, Janssen Inc., to advance three technologies focused on cardiac, diabetes and depression, respectively.

This announcement was covered in Lab Product News.

“These three projects reflect the quality of innovation present in Toronto’s research community for our industry partners, and Toronto’s progress in addressing healthcare issues of international concern,” said Dr. Raphael Hofstein, president and CEO of MaRS Innovation. “Johnson & Johnson Innovation is a long-term strategic partner of MaRS Innovation and of our members; our collaboration reflects the benefits to accessing our members’ deal flow through MaRS Innovation. Through these deals and other scientific exchanges, we see increased interest in Toronto’s innovation and entrepreneurship community.”

The projects’ principal investigators are researchers from the University Health Network (UHN), the Centre for Addiction and Mental Health (CAMH) and the University of Toronto. This announcement follows Johnson & Johnson Innovation’s December 2013 commitment to collaborate on early-stage drug development projects.

Continue Reading

Baycrest’s “My Virtual Dream” brain exhibit at Ontario Science Centre Jan 17-18, 2015

MaRS Innovation is a My Virtual Dream event sponsor and commercialization partner

Baycrest Logo 2015Toronto, ON (January 12, 2015) – Baycrest Health Sciences’ dazzling brain science exhibit from 2013 Scotiabank Nuit Blanche will be on show at the Ontario Science Centre’s BRAINFest, Jan. 17-18.

My Virtual Dream is an innovative and interactive live performance experience at the intersection of science, art and music.  The installation will enable participants to use their brain waves to communicate with each other through an immersive audio and visual expression that will be projected onto video screens.

“Participating at BRAINFest is a great way to share Baycrest’s renowned strengths in cognitive neuroscience in a highly artistic and interactive way with the public,” says Dr. Randy McIntosh, vice-president of Research and Director of Baycrest’s Rotman Research Institute. “Baycrest wishes to thank the Ontario Brain Institute for bringing My Virtual Dream into the Ontario Science Centre and to MaRS Innovation as our key collaborative partner.”

The concept for My Virtual Dream is inspired by an ongoing international project led by Dr. McIntosh and the Rotman to build a virtual, functional brain – a research and diagnostic tool that could one day revolutionize brain healthcare.

The installation, created by Baycrest and the University of Toronto for Nuit Blanche 2013, was a huge hit with fans of the festival. It also represented an extraordinary neuroscience experiment that explored how people can collectively synchronize their brain waves to co-create a multi-sensory environment that merges art, science and technology. In a single night, Rotman researchers collected brain data from over 500 people who signed on to be research subjects.

Continue Reading
Back To Top